Enzon Pharma (ENZN) Cash Flow Statement

Click line-items for a historical chart and %

Net (loss) income	-1.13M
Income and gain from discontinued operations
(Loss) income from continuing operations
Depreciation
Amortization and write-off of debt issuance costs
Share-based compensation
Write-down of property and equipment
Loss on disposal of fixed assets
Gain on sale of marketable securities
Changes in operating assets and liabilities
Net cash (used in) provided by operating activities of continuing operations	2.6M
Net cash provided by operating activities of discontinued operations
Net cash (used in) provided by operating activities
Proceeds from sale of business, net
Purchases of property and equipment
Proceeds from sales of fixed assets
Proceeds from sales and maturities of marketable securities
Purchases of marketable securities
Net cash provided by investing activities of continuing operations
Net cash used in investing activities of discontinued operations
Net cash provided by investing activities
Repurchases of common stock
Proceeds from issuance of common stock
Withholding taxes – share-based compensation	0
Redemptions from employee stock purchase plan, net
Net cash (used in) provided by financing activities
Net (decrease) increase in cash and cash equivalents	-4.03M
Cash and cash equivalents at beginning of period	11.67M
Cash and cash equivalents at end of period	7.64M

Entities mentioned with ENZN

View All Entities